PAMS
ITCI
Pictet Asset Management (Switzerland)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $106M | Buy |
1,671,846
+490,242
| +41% | +$31M | 0.13% | 189 |
|
|
2023
Q1 | $64M | Buy |
1,181,604
+182,612
| +18% | +$9.89M | 0.08% | 253 |
|
|
2022
Q4 | $52.9M | Buy |
998,992
+154,068
| +18% | +$8.15M | 0.08% | 261 |
|
|
2022
Q3 | $39.3M | Sell |
844,924
-268,658
| -24% | -$12.5M | 0.06% | 309 |
|
|
2022
Q2 | $63.6M | Sell |
1,113,582
-371,906
| -25% | -$21.2M | 0.09% | 247 |
|
|
2022
Q1 | $90.9M | Buy |
1,485,488
+30,614
| +2% | +$1.87M | 0.1% | 230 |
|
|
2021
Q4 | $76.1M | Buy |
+1,454,874
| New | +$76.1M | 0.08% | 269 |
|